silver acetate has been researched along with Cardiovascular Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Black, SR; Fennell, TR; Harrington, JM; Holland, NA; Levine, KE; Mortensen, NP; Pathmasiri, W; Poitras, E; Snyder, RW; Sumner, SC; Wingard, CJ | 1 |
1 other study(ies) available for silver acetate and Cardiovascular Diseases
Article | Year |
---|---|
Disposition of intravenously or orally administered silver nanoparticles in pregnant rats and the effect on the biochemical profile in urine.
Topics: Acetates; Administration, Intravenous; Administration, Oral; Adult; Cardiovascular Diseases; Cytokines; Female; Fetus; Humans; Maternal-Fetal Exchange; Metabolomics; Metal Nanoparticles; Oxidative Stress; Particle Size; Placenta; Pregnancy; Silver; Silver Compounds; Tissue Distribution | 2017 |